LRRK2 and Parkinson disease: Compared to pS1292-LRRK2 levels in urinary exosomes, CSF levels were much higher (about 5-fold) but failed to discriminate LRRK2 mutation carriers/PD patients from non-carriers/controls, possibly due to saturation effects.